0001127602-21-015715.txt : 20210506
0001127602-21-015715.hdr.sgml : 20210506
20210506160802
ACCESSION NUMBER: 0001127602-21-015715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210504
FILED AS OF DATE: 20210506
DATE AS OF CHANGE: 20210506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENDERSON LORI M.
CENTRAL INDEX KEY: 0001221127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 21897764
MAIL ADDRESS:
STREET 1: MOLDFLOW CORP
STREET 2: 430 BOSTON POST ROAD
CITY: WAYLAND
STATE: MA
ZIP: 01778
FORMER NAME:
FORMER CONFORMED NAME: HENDERSON LORI M
DATE OF NAME CHANGE: 20030228
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-05-04
0001682852
Moderna, Inc.
MRNA
0001221127
HENDERSON LORI M.
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
General Counsel and Secretary
Common Stock
2021-05-04
4
M
0
6600
20.93
A
7501
D
Common Stock
2021-05-04
4
S
0
6600
185.25
D
901
D
Stock Option (Right to Buy)
20.93
2021-05-04
4
M
0
6600
0
D
2029-03-08
Common Stock
6600
100076
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
/s/ Brian Sandstrom, as Attorney-in-Fact
2021-05-06